@article{c02487216d3248848b6c1ccf8fc5a641,
title = "Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy",
keywords = "recombinant blood clotting factor 8, blood clotting factor 8, adolescent, adult, Article, clinical outcome, controlled study, cost effectiveness analysis, disease severity, health status, hemophilia A, human, Italy, late prophylaxis, on demand therapy, patient compliance, priority journal, prophylaxis, quality adjusted life year, sensitivity analysis, therapy, cost benefit analysis, economics, Markov chain, quality of life, Cost-Benefit Analysis, Factor VIII, Hemophilia A, Humans, Markov Chains, Quality of Life",
author = "A. Coppola and A. D'Ausilio and A. Aiello and S. Amoresano and M. Toumi and P. Mathew and A. Tagliaferri and Group, {the Potter Study} and G. Feola and A.C. Molinari and C. Santoro and G.F. Rivolta and D.B. Cultrera and F. Gagliano and E. Zanon and M.E. Mancuso and L. Valdr{\`e} and L. Mameli and L. Banov and {Di Minno}, G. and G. Quintavalle and M.G. Mazzucconi and N. Negri and E. Santagostino",
year = "2017",
doi = "10.1111/hae.13185",
language = "English",
volume = "23",
pages = "422--429",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",
}